{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:39:04Z","timestamp":1763620744592,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.dld.2020.05.032","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T21:58:33Z","timestamp":1591739913000},"page":"995-1001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Motivation to pursue anti-TNF\u03b1 treatment in patients with Crohn's disease \u2013 the SPACE motivation study"],"prefix":"10.1016","volume":"52","author":[{"given":"Ferdinando","family":"D'Amico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Vandromme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoram","family":"Bouhnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Faure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Nahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Hagege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Hebuterne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Benkhalifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Nachury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10080","key":"10.1016\/j.dld.2020.05.032_bib0001","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2020.05.032_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEG.S4512","article-title":"The impact of biologics on health-related quality of life in patients with inflammatory bowel disease","volume":"2","author":"Vogelaar","year":"2009","journal-title":"Clin Exp Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2020.05.032_bib0003","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gutjnl-2011-301971","article-title":"Factors affecting outcomes in Crohn's disease over 15 years","volume":"61","author":"Cosnes","year":"2012","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.dld.2020.05.032_bib0004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2020.05.032_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13847","article-title":"Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis","volume":"45","author":"Mao","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dld.2020.05.032_bib0006","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/MIB.0000000000000061","article-title":"Utilization trends of anti-TNF agents and health outcomes in adults and children with inflammatory bowel diseases: a single-center experience","volume":"20","author":"Park","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.dld.2020.05.032_bib0007","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cgh.2017.01.035","article-title":"Temporal trends in initiation of therapy with tumor necrosis factor antagonists for patients with inflammatory bowel disease: a population-based analysis","volume":"15","author":"Targownik","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2020.05.032_bib0008","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.13835","article-title":"et al. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014","volume":"45","author":"Kirchgesner","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.dld.2020.05.032_bib0009","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/j.gastro.2005.01.048","article-title":"Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease","volume":"128","author":"Lichtenstein","year":"2005","journal-title":"Gastroenterology"},{"issue":"27","key":"10.1016\/j.dld.2020.05.032_bib0010","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.3748\/wjg.v19.i27.4344","article-title":"Low rates of adherence for tumor necrosis factor-\u03b1 inhibitors in Crohn's disease and rheumatoid arthritis: results of a systematic review","volume":"19","author":"Fidder","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2020.05.032_bib0011","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0016-5085(99)70332-X","article-title":"et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease","volume":"117","author":"Rutgeerts","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.dld.2020.05.032_bib0012","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.dld.2020.05.032_bib0013","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/apt.13083","article-title":"Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed","volume":"41","author":"Gisbert","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.dld.2020.05.032_bib0014","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/j.gastro.2015.08.055","article-title":"Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease","volume":"149","author":"Torres","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2020.05.032_bib0015","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ajg.2016.54","article-title":"The risk of relapse after anti-tnf discontinuation in inflammatory bowel disease: systematic review and meta-analysis","volume":"111","author":"Gisbert","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.032_bib0016","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/PPA.S24752","article-title":"A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence","volume":"6","author":"Barbosa","year":"2012","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.dld.2020.05.032_bib0017","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J Psychosom Res"},{"issue":"3","key":"10.1016\/j.dld.2020.05.032_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1369-7625.2010.00619.x","article-title":"Frequency of and reasons for medication non-fulfillment and non-persistence among American adults with chronic disease in 2008","volume":"14","author":"McHorney","year":"2011","journal-title":"Health Expect"},{"issue":"8","key":"10.1016\/j.dld.2020.05.032_bib0019","doi-asserted-by":"crossref","first-page":"659","DOI":"10.14740\/jocmr3081w","article-title":"The influence of motivational interviewing on patients with inflammatory bowel disease: a systematic review of the literature","volume":"9","author":"Wagoner","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.dld.2020.05.032_bib0020","first-page":"173","article-title":"et al. Assessing patients\u2019 satisfaction with anti-TNF\u03b1 treatment in Crohn's disease: qualitative steps of the development of a new questionnaire","volume":"4","author":"Marant","year":"2011","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.dld.2020.05.032_bib0021","first-page":"1671","article-title":"et al. Measuring patients\u2019 satisfaction with their anti-TNF treatment in severe Crohn's disease: scoring and psychometric validation of the satisfaction for patients in Crohn's disease questionnaire (SPACE-Q(\u00a9))","volume":"8","author":"Gilet","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"6","key":"10.1016\/j.dld.2020.05.032_bib0022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.erap.2014.08.005","article-title":"Validation of the French version of the beliefs about medicines questionnaire (BMQ) among diabetes and HIV patients","volume":"64","author":"Fall","year":"2014","journal-title":"Euro Rev Appl Psychol"},{"issue":"4 Pt 1","key":"10.1016\/j.dld.2020.05.032_bib0023","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1475-6773.2004.00269.x","article-title":"Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers","volume":"39","author":"Hibbard","year":"2004","journal-title":"Health Serv Res"},{"issue":"6 Pt 1","key":"10.1016\/j.dld.2020.05.032_bib0024","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1475-6773.2005.00438.x","article-title":"Development and testing of a short form of the patient activation measure","volume":"40","author":"Hibbard","year":"2005","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.dld.2020.05.032_bib0025","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/occmed\/kqu024","article-title":"The hospital anxiety and depression scale","volume":"64","author":"Stern","year":"2014","journal-title":"Occup Med (Lond)"},{"issue":"2","key":"10.1016\/j.dld.2020.05.032_bib0026","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.comppsych.2008.06.010","article-title":"The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health","volume":"50","author":"Misdrahi","year":"2009","journal-title":"Compr Psychiatry"},{"issue":"5","key":"10.1016\/j.dld.2020.05.032_bib0027","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","article-title":"Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review","volume":"16","author":"de Jong","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2020.05.032_bib0028","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0191-8869(98)00086-5","article-title":"How to score questionnaires","volume":"25","author":"Hofstee","year":"1998","journal-title":"Pers Individ Differ"},{"issue":"1","key":"10.1016\/j.dld.2020.05.032_bib0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12325-016-0441-3","article-title":"et al. Impact of treatment-related beliefs on medication adherence in immune-mediated Inflammatory diseases: results of the global ALIGN study","volume":"34","author":"Michetti","year":"2017","journal-title":"Adv Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820302383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865820302383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:12:01Z","timestamp":1761624721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865820302383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1590865820302383"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2020.05.032","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motivation to pursue anti-TNF\u03b1 treatment in patients with Crohn's disease \u2013 the SPACE motivation study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2020.05.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}